About Transcription factor GATA-4
Transcription factor GATA-4 (GATA4) is a protein
from Homo sapiens identified by UniProt accession
P43694, 442 residues long.
MolForge cross-references it against 0 known binders and
548 disease associations.
Target properties
| Protein name | Transcription factor GATA-4 |
| UniProt accession | P43694 |
| Gene | GATA4 |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (548)
Diseases linked to this target (Open Targets).
- atrial septal defect 2 · score 0.81
- ventricular septal defect 1 · score 0.79
- Tetralogy of Fallot · score 0.74
- atrioventricular septal defect 4 · score 0.71
- congenital heart disease · score 0.66
- 46,XY partial gonadal dysgenesis · score 0.59
- neurodegenerative disease · score 0.52
- pancreatic hypoplasia-diabetes-congenital heart disease syndrome · score 0.46
- familial atrial fibrillation · score 0.38
- systolic blood pressure · score 0.38
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P43694-F1 | alphafold | PREDICTED | 57.20 | — |
Amino-acid sequence (442 residues)
MYQSLAMAAN HGPPPGAYEA GGPGAFMHGA GAASSPVYVP TPRVPSSVLG LSYLQGGGAG SASGGASGGS SGGAASGAGP GTQQGSPGWS QAGADGAAYT PPPVSPRFSF PGTTGSLAAA AAAAAAREAA AYSSGGGAAG AGLAGREQYG RAGFAGSYSS PYPAYMADVG ASWAAAAAAS AGPFDSPVLH SLPGRANPAA RHPNLDMFDD FSEGRECVNC GAMSTPLWRR DGTGHYLCNA CGLYHKMNGI NRPLIKPQRR LSASRRVGLS CANCQTTTTT LWRRNAEGEP VCNACGLYMK LHGVPRPLAM RKEGIQTRKR KPKNLNKSKT PAAPSGSESL PPASGASSNS SNATTSSSEE MRPIKTEPGL SSHYGHSSSV SQTFSVSAMS GHGPSIHPVL SALKLSPQGY ASPVSQSPQT SSKQDSWNSL VLADSHGDII TA
Explore Transcription factor GATA-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets